the future of money is digital currency- Top snippets

Reserve Bank of Australia: Potential inflation is still too high. There is still uncertainty about the prospects. The Committee is increasingly convinced that inflationary pressure is decreasing with the recent forecast, but the risk still exists. The Committee will continue to rely on data and changing risk assessments to guide its decision-making. Although the potential inflation is still at a high level, other recent economic activity data are mixed, but overall, November data is weaker than expected.Reserve Bank of Australia President Brock: The policy needs to be carefully considered. Recent data are mixed and somewhat weak.LI: In the 49th week of 2024 (12.2-12.8), the weekly sales volume of LI reached 12,600 vehicles, ranking first in the sales volume of new power brands in China market for 33 consecutive weeks.

Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.Broad-based index products are expected to increase the Y share of personal pension, and personal pension products are expected to expand after the second anniversary of the personal pension system. It is understood that mainstream broad-based index products are expected to increase the personal pension Y share, including Shanghai and Shenzhen 300 Index, CSI 500 Index, CSI A500 Index, GEM Index and other products, which can provide investors with more allocation needs.Afternoon comment: The Shanghai Composite Index rose more than 1% in half a day, and consumer concept stocks broke out collectively. The index was active in early trading. The Shanghai Composite Index rose more than 1% in half a day, and the Shanghai Composite Index rose more than 2%. In terms of sectors, robot concept stocks continued to break out, and the concept of PEEK materials led the rise. Both China Research Institute and Xinyi New Materials had a daily limit of 20cm, while Zhongxin Fluorescent Materials and Walter shares touched the daily limit; The large consumer sector collectively rose, with dairy stocks leading the gains, and Panda Dairy, Western Animal Husbandry and Li Ziyuan were trading daily; AI concept stocks fluctuated higher, and it is worth buying 20cm daily limit, Hanwang Technology, Xinhua Media and other daily limit; Insurance stocks strengthened, and Tianli Technology, Astar, Focus Technology and other daily limit. Overall, individual stocks showed a general upward trend, with more than 4,600 stocks rising. On the disk, all sectors in the two cities generally rose, with PEEK materials, film and television theaters and dairy sectors among the top gainers.

The Reserve Bank of Australia maintains the interest rate at a 13-year high, suggesting that it has made progress in fighting inflation. The Reserve Bank of Australia maintains the key interest rate at a 13-year high to cope with stubborn price pressure, while suggesting that it has made some progress in fighting inflation. The Reserve Bank of Australia kept the cash interest rate unchanged at 4.35% on Tuesday. As widely expected, it has kept the interest rate at this level for more than a year. The Monetary Policy Committee said that "there is some confidence that inflation is moving towards the target in a sustainable way". Australian dollar and policy-sensitive 3-year Australian government bond yields fell. Since the last meeting of the Reserve Bank of Australia, the Australian dollar has fallen by about 3% against the US dollar, while Australian government bonds have risen due to the expectation of interest rate cuts as early as February next year.US prosecutors have filed murder charges against the suspect in the murder of a joint health executive.Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.